ArticleActa Cardiologica Sinica2013
The Effects of Fasudil at Different Doses on Acute Myocardial Infarction in Rats.
Article in Acta Cardiologica Sinica, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Fasudil protects spiral ganglion neurons and hair cells against cisplatin-induced apoptosis by inhibiting reactive oxygen species accumulation and regulating the ROCK/PTEN/AKT signaling pathway.Toxicology research · 2025Article
- The combination approach with Rhokinase inhibition and mechanical circulatory support in myocardial ischemia-reperfusion injury: Rho-kinase inhibition and ventricular unloading.Asian cardiovascular & thoracic annals · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo explore the effects of different doses of fasudil on cardiomyocytes in rats with acute myocardial infarction (AMI).
methodsA model of rats experiencing AMI was randomly divided into control groups and fasudil treatment groups according to the different doses of fasudil. After four weeks, hemodynamic parameters were measured. Expression levels of Rho kinase mRNA by the reverse transcription polymerase chain reaction method and the expression levels of apoptosis related proteins, Bcl-2 and bax, were determined by the immunohistochemical method.
resultsIn the model of AMI in rats, their hemodynamic deteriorated, and the expression level of the Rho kinase mRNA increased in the myocardial tissue; but the expression level of apoptosis-related protein bcl-2 decreased, and Bax increased (p < 0.01). After the administration of fasudil, hemodynamic levels improved (p < 0.05), expression levels of Rho kinase mRNA and Bax (p < 0.01) decreased, expression levels of bcl-2 increased, and with the added element of dosage increase, the effect was significant (p < 0.05).
conclusionsBy administration of different doses of fasudil, the expression level of Rho kinase in myocardial tissue decreased and apoptosis reduced in rats with AMI. Fasudil plays an important role in protecting ischemic myocardium and improving cardiac function post AMI in rats, the effects of which were enhanced as the dosage was increased. KEY WORDS: Apoptosis; Myocardial infarction; Rho kinase.
Identifiers
27122753PMC4805031W2129467278What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.